Clinical Trials Directory

Trials / Completed

CompletedNCT04971863

In-vivo Behavior of Asqelio Monofocal Biaspheric Intraocular Lens

In-vivo Behavior of Asqelio Monofocal Biaspheric Intraocular Lens. Two-year Follow-up

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
AST Products, Inc. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

This is a study to evaluate the 24 month postoperative incidence and intensity of posterior capsular opacity in patients submitted to cataract surgery and implanted with a hydrophobic monofocal IOL.

Detailed description

This study is a two-arm masked clinical evaluation study of incidence of PCO after successful bilateral cataract surgery with implantation of a monofocal IOL. Subjects will be assessed 24 months after IOL implantation. Clinical evaluations will include incidence of adverse events, patient satisfaction questionnaire, as well as measurements of visual performance, optical quality, presence and intensity of PCO, presence and intensity of IOL glistening.

Conditions

Timeline

Start date
2022-03-30
Primary completion
2023-10-31
Completion
2024-01-05
First posted
2021-07-22
Last updated
2024-01-31

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04971863. Inclusion in this directory is not an endorsement.

In-vivo Behavior of Asqelio Monofocal Biaspheric Intraocular Lens (NCT04971863) · Clinical Trials Directory